Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Pergamum AB
DescriptionTopical gel formulation of cathelicidin antimicrobial peptide (CAMP; LL37)
Molecular Target Cathelicidin antimicrobial peptide (CAMP) (CRAMP) (LL37)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase I/II
Standard IndicationDermal ulcers
Indication DetailsTreat chronic venous leg ulcers
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today